Replies to post #336458 on NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

I agree with most of that.

Woodford was a star at Invesco, but lacked that large company support system in his own firm. Perhaps that success was as much a product of the Invesco environment as his own savvy?

Having been a PM, the part that mystifies me is the total disregard for risk, combined with challenging liquidity. If you want to run a risky low-liquidity strategy, including non-traded stock, do it in a long term partnership or a closed-end fund. Certainly not in funds with daily redemptions.

Specific to nwbo, his due diligence was poor. Then his buying was extremely sloppy. I think he personally pushed nwbo from $5 to $12 bidding against himself. It is hard to understand him missing the governance issues, yet he did. It seems we largely agree on his subsequent mistakes.